| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | androsterone dehydrogenase (B-specific) activity | 1.20e-09 | 4 | 119 | 4 | GO:0047042 | |
| GeneOntologyMolecularFunction | ketoreductase activity | 1.20e-09 | 4 | 119 | 4 | GO:0045703 | |
| GeneOntologyMolecularFunction | chlordecone reductase activity | 1.20e-09 | 4 | 119 | 4 | GO:0047743 | |
| GeneOntologyMolecularFunction | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity | 5.97e-09 | 5 | 119 | 4 | GO:0047115 | |
| GeneOntologyMolecularFunction | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity | 5.97e-09 | 5 | 119 | 4 | GO:0047020 | |
| GeneOntologyMolecularFunction | 17-beta-ketosteroid reductase (NADPH) activity | 5.97e-09 | 5 | 119 | 4 | GO:0072555 | |
| GeneOntologyMolecularFunction | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity | 5.97e-09 | 5 | 119 | 4 | GO:0047006 | |
| GeneOntologyMolecularFunction | lithocholic acid binding | 5.97e-09 | 5 | 119 | 4 | GO:1902121 | |
| GeneOntologyMolecularFunction | ketosteroid monooxygenase activity | 5.97e-09 | 5 | 119 | 4 | GO:0047086 | |
| GeneOntologyMolecularFunction | Delta4-3-oxosteroid 5beta-reductase activity | 5.97e-09 | 5 | 119 | 4 | GO:0047787 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 1.78e-08 | 6 | 119 | 4 | GO:0045550 | |
| GeneOntologyMolecularFunction | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity | 4.14e-08 | 7 | 119 | 4 | GO:0072582 | |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 8.24e-08 | 8 | 119 | 4 | GO:0047024 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase activity | 8.24e-08 | 8 | 119 | 4 | GO:0047023 | |
| GeneOntologyMolecularFunction | enone reductase activity | 8.24e-08 | 8 | 119 | 4 | GO:0035671 | |
| GeneOntologyMolecularFunction | androstan-3-alpha,17-beta-diol dehydrogenase activity | 1.48e-07 | 9 | 119 | 4 | GO:0047044 | |
| GeneOntologyMolecularFunction | NADP+ binding | 1.48e-07 | 9 | 119 | 4 | GO:0070401 | |
| GeneOntologyMolecularFunction | testosterone 17-beta-dehydrogenase (NADP+) activity | 2.45e-07 | 10 | 119 | 4 | GO:0047045 | |
| GeneOntologyMolecularFunction | bile acid binding | 2.45e-07 | 10 | 119 | 4 | GO:0032052 | |
| GeneOntologyMolecularFunction | NADPH binding | 4.11e-07 | 26 | 119 | 5 | GO:0070402 | |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 1.15e-06 | 14 | 119 | 4 | GO:0004032 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 1.15e-06 | 14 | 119 | 4 | GO:0001758 | |
| GeneOntologyMolecularFunction | NADP binding | 1.85e-06 | 62 | 119 | 6 | GO:0050661 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 2.69e-06 | 17 | 119 | 4 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 2.69e-06 | 17 | 119 | 4 | GO:0019198 | |
| GeneOntologyMolecularFunction | estradiol 17-beta-dehydrogenase [NAD(P)+] activity | 5.40e-06 | 20 | 119 | 4 | GO:0004303 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 1.16e-05 | 24 | 119 | 4 | GO:0004745 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 1.62e-05 | 26 | 119 | 4 | GO:0004022 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 1.89e-05 | 27 | 119 | 4 | GO:0008106 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 2.92e-05 | 30 | 119 | 4 | GO:0018455 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase [NAD(P)+] activity | 3.29e-05 | 11 | 119 | 3 | GO:0030283 | |
| GeneOntologyMolecularFunction | aldo-keto reductase (NADPH) activity | 3.79e-05 | 32 | 119 | 4 | GO:0004033 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 4.29e-05 | 33 | 119 | 4 | GO:0033764 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 4.84e-05 | 34 | 119 | 4 | GO:0016628 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 8.39e-05 | 39 | 119 | 4 | GO:0016229 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 9.28e-05 | 40 | 119 | 4 | GO:0016709 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor | 1.91e-04 | 48 | 119 | 4 | GO:0016620 | |
| GeneOntologyMolecularFunction | indanol dehydrogenase activity | 2.10e-04 | 4 | 119 | 2 | GO:0047718 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the aldehyde or oxo group of donors | 3.47e-04 | 56 | 119 | 4 | GO:0016903 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor | 4.52e-04 | 60 | 119 | 4 | GO:0016655 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors | 5.12e-04 | 62 | 119 | 4 | GO:0016627 | |
| GeneOntologyMolecularFunction | rRNA (cytosine) methyltransferase activity | 5.20e-04 | 6 | 119 | 2 | GO:0016434 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 9.85e-04 | 127 | 119 | 5 | GO:0016616 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA4 ERCC6L ABCA12 MYO10 MCM2 NLRP1 MCM6 IDE DDX5 KIF9 HELLS | 1.11e-03 | 614 | 119 | 11 | GO:0140657 |
| GeneOntologyMolecularFunction | testosterone dehydrogenase (NAD+) activity | 1.23e-03 | 9 | 119 | 2 | GO:0047035 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | 1.31e-03 | 441 | 119 | 9 | GO:0016887 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 1.43e-03 | 138 | 119 | 5 | GO:0016614 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H | 2.51e-03 | 95 | 119 | 4 | GO:0016651 | |
| GeneOntologyMolecularFunction | helicase activity | 2.58e-03 | 158 | 119 | 5 | GO:0004386 | |
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | 3.37e-03 | 103 | 119 | 4 | GO:0004725 | |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 3.86e-03 | 107 | 119 | 4 | GO:0033293 | |
| GeneOntologyMolecularFunction | 3'-5' DNA helicase activity | 4.00e-03 | 16 | 119 | 2 | GO:0043138 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 4.99e-03 | 115 | 119 | 4 | GO:0004497 | |
| GeneOntologyMolecularFunction | molecular sequestering activity | 5.26e-03 | 59 | 119 | 3 | GO:0140313 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 5.40e-03 | 188 | 119 | 5 | GO:0005201 | |
| GeneOntologyMolecularFunction | endopeptidase activator activity | 5.64e-03 | 19 | 119 | 2 | GO:0061133 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCA4 ERCC6L ABCA12 MCM2 NLRP1 MCM6 IDE DDX5 RGS14 GUF1 KIF9 | 6.61e-03 | 775 | 119 | 11 | GO:0017111 |
| GeneOntologyBiologicalProcess | response to jasmonic acid | 1.02e-09 | 4 | 118 | 4 | GO:0009753 | |
| GeneOntologyBiologicalProcess | progesterone catabolic process | 1.02e-09 | 4 | 118 | 4 | GO:0006709 | |
| GeneOntologyBiologicalProcess | cellular response to jasmonic acid stimulus | 1.02e-09 | 4 | 118 | 4 | GO:0071395 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone catabolic process | 1.02e-09 | 4 | 118 | 4 | GO:0008208 | |
| GeneOntologyBiologicalProcess | farnesol metabolic process | 5.07e-09 | 5 | 118 | 4 | GO:0016487 | |
| GeneOntologyBiologicalProcess | farnesol catabolic process | 5.07e-09 | 5 | 118 | 4 | GO:0016488 | |
| GeneOntologyBiologicalProcess | negative regulation of isoprenoid metabolic process | 5.07e-09 | 5 | 118 | 4 | GO:0045827 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid catabolic process | 5.07e-09 | 5 | 118 | 4 | GO:0016107 | |
| GeneOntologyBiologicalProcess | olefinic compound catabolic process | 5.07e-09 | 5 | 118 | 4 | GO:0120256 | |
| GeneOntologyBiologicalProcess | negative regulation of retinoic acid biosynthetic process | 5.07e-09 | 5 | 118 | 4 | GO:1900053 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid metabolic process | 1.51e-08 | 6 | 118 | 4 | GO:0006714 | |
| GeneOntologyBiologicalProcess | polyprenol catabolic process | 1.51e-08 | 6 | 118 | 4 | GO:0016095 | |
| GeneOntologyBiologicalProcess | response to prostaglandin D | 3.52e-08 | 7 | 118 | 4 | GO:0071798 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin D stimulus | 3.52e-08 | 7 | 118 | 4 | GO:0071799 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid biosynthetic process | 3.52e-08 | 7 | 118 | 4 | GO:1900052 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 1.06e-07 | 21 | 118 | 5 | GO:0042447 | |
| GeneOntologyBiologicalProcess | retinal metabolic process | 1.06e-07 | 21 | 118 | 5 | GO:0042574 | |
| GeneOntologyBiologicalProcess | daunorubicin metabolic process | 1.25e-07 | 9 | 118 | 4 | GO:0044597 | |
| GeneOntologyBiologicalProcess | doxorubicin metabolic process | 2.08e-07 | 10 | 118 | 4 | GO:0044598 | |
| GeneOntologyBiologicalProcess | regulation of isoprenoid metabolic process | 2.08e-07 | 10 | 118 | 4 | GO:0019747 | |
| GeneOntologyBiologicalProcess | negative regulation of vitamin metabolic process | 2.08e-07 | 10 | 118 | 4 | GO:0046137 | |
| GeneOntologyBiologicalProcess | polyketide metabolic process | 2.08e-07 | 10 | 118 | 4 | GO:0030638 | |
| GeneOntologyBiologicalProcess | aminoglycoside antibiotic metabolic process | 2.08e-07 | 10 | 118 | 4 | GO:0030647 | |
| GeneOntologyBiologicalProcess | regulation of testosterone biosynthetic process | 3.26e-07 | 11 | 118 | 4 | GO:2000224 | |
| GeneOntologyBiologicalProcess | terpenoid catabolic process | 3.26e-07 | 11 | 118 | 4 | GO:0016115 | |
| GeneOntologyBiologicalProcess | retinoic acid biosynthetic process | 9.75e-07 | 14 | 118 | 4 | GO:0002138 | |
| GeneOntologyBiologicalProcess | isoprenoid catabolic process | 9.75e-07 | 14 | 118 | 4 | GO:0008300 | |
| GeneOntologyBiologicalProcess | diterpenoid biosynthetic process | 1.32e-06 | 15 | 118 | 4 | GO:0016102 | |
| GeneOntologyBiologicalProcess | testosterone biosynthetic process | 1.76e-06 | 16 | 118 | 4 | GO:0061370 | |
| GeneOntologyBiologicalProcess | negative regulation of hormone metabolic process | 1.76e-06 | 16 | 118 | 4 | GO:0032351 | |
| GeneOntologyBiologicalProcess | regulation of vitamin metabolic process | 2.93e-06 | 18 | 118 | 4 | GO:0030656 | |
| GeneOntologyBiologicalProcess | terpenoid biosynthetic process | 5.65e-06 | 21 | 118 | 4 | GO:0016114 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid receptor signaling pathway | 5.65e-06 | 21 | 118 | 4 | GO:0048385 | |
| GeneOntologyBiologicalProcess | ketone catabolic process | 5.65e-06 | 21 | 118 | 4 | GO:0042182 | |
| GeneOntologyBiologicalProcess | parturition | 6.88e-06 | 22 | 118 | 4 | GO:0007567 | |
| GeneOntologyBiologicalProcess | glycoside metabolic process | 6.88e-06 | 22 | 118 | 4 | GO:0016137 | |
| GeneOntologyBiologicalProcess | progesterone metabolic process | 6.88e-06 | 22 | 118 | 4 | GO:0042448 | |
| GeneOntologyBiologicalProcess | tertiary alcohol metabolic process | 6.88e-06 | 22 | 118 | 4 | GO:1902644 | |
| GeneOntologyBiologicalProcess | neuron development | EPHB2 CUL4B CACNA1F TMEM67 FAT4 NCKAP1 HTRA2 PLEKHG4 USP9X SYNE1 SPAG6 TENM2 YWHAZ SEMA3A PTK2B BMP7 SRGAP2C PTPRF PTPRG WASHC5 PTPRZ1 PCDH15 ULK2 | 7.89e-06 | 1463 | 118 | 23 | GO:0048666 |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin stimulus | 8.29e-06 | 23 | 118 | 4 | GO:0071379 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 8.29e-06 | 23 | 118 | 4 | GO:0034310 | |
| GeneOntologyBiologicalProcess | regulation of ketone biosynthetic process | 1.38e-05 | 26 | 118 | 4 | GO:0010566 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA splicing, via spliceosome | 1.87e-05 | 28 | 118 | 4 | GO:0048025 | |
| GeneOntologyBiologicalProcess | polyprenol metabolic process | 2.16e-05 | 29 | 118 | 4 | GO:0016093 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA processing | 2.16e-05 | 29 | 118 | 4 | GO:0050686 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | EPHB2 TMEM67 NCKAP1 MYO10 SYNE1 SDCCAG8 TENM2 SEMA3A PTK2B BMP7 SRGAP2C PTPRF PTPRG WASHC5 PTPRZ1 ULK2 | 2.59e-05 | 846 | 118 | 16 | GO:0120035 |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 3.13e-05 | 105 | 118 | 6 | GO:0006721 | |
| GeneOntologyBiologicalProcess | positive regulation of endothelial cell apoptotic process | 3.23e-05 | 32 | 118 | 4 | GO:2000353 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | EPHB2 TMEM67 NCKAP1 MYO10 SYNE1 SDCCAG8 TENM2 SEMA3A PTK2B BMP7 SRGAP2C PTPRF PTPRG WASHC5 PTPRZ1 ULK2 | 3.29e-05 | 863 | 118 | 16 | GO:0031344 |
| GeneOntologyBiologicalProcess | negative regulation of RNA splicing | 3.66e-05 | 33 | 118 | 4 | GO:0033119 | |
| GeneOntologyBiologicalProcess | neuron projection development | EPHB2 CUL4B CACNA1F FAT4 NCKAP1 PLEKHG4 USP9X SYNE1 SPAG6 TENM2 SEMA3A PTK2B BMP7 SRGAP2C PTPRF PTPRG WASHC5 PTPRZ1 PCDH15 ULK2 | 3.90e-05 | 1285 | 118 | 20 | GO:0031175 |
| GeneOntologyBiologicalProcess | steroid catabolic process | 4.13e-05 | 34 | 118 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | olefinic compound biosynthetic process | 4.65e-05 | 35 | 118 | 4 | GO:0120255 | |
| GeneOntologyBiologicalProcess | response to fatty acid | 4.72e-05 | 69 | 118 | 5 | GO:0070542 | |
| GeneOntologyBiologicalProcess | response to prostaglandin | 5.20e-05 | 36 | 118 | 4 | GO:0034694 | |
| GeneOntologyBiologicalProcess | isoprenoid biosynthetic process | 5.20e-05 | 36 | 118 | 4 | GO:0008299 | |
| GeneOntologyBiologicalProcess | retinoic acid receptor signaling pathway | 6.46e-05 | 38 | 118 | 4 | GO:0048384 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 7.93e-05 | 40 | 118 | 4 | GO:0042573 | |
| GeneOntologyBiologicalProcess | filopodium assembly | 8.51e-05 | 78 | 118 | 5 | GO:0046847 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection assembly | 9.15e-05 | 248 | 118 | 8 | GO:0120032 | |
| GeneOntologyBiologicalProcess | cellular response to fatty acid | 9.63e-05 | 42 | 118 | 4 | GO:0071398 | |
| GeneOntologyBiologicalProcess | synaptic target recognition | 9.70e-05 | 3 | 118 | 2 | GO:0008039 | |
| GeneOntologyBiologicalProcess | regulation of cell projection assembly | 9.94e-05 | 251 | 118 | 8 | GO:0060491 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | FAT4 HTRA2 USP9X CAT AKR1C4 SMOC2 AKR1C1 AKR1C2 FGF17 DDX5 BMP7 PELO GPC3 PTPRF AKR1C3 | 1.03e-04 | 850 | 118 | 15 | GO:0071363 |
| GeneOntologyBiologicalProcess | C21-steroid hormone metabolic process | 1.27e-04 | 45 | 118 | 4 | GO:0008207 | |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 1.50e-04 | 47 | 118 | 4 | GO:0046164 | |
| GeneOntologyBiologicalProcess | response to growth factor | FAT4 HTRA2 USP9X CAT AKR1C4 SMOC2 AKR1C1 AKR1C2 FGF17 DDX5 BMP7 PELO GPC3 PTPRF AKR1C3 | 1.56e-04 | 883 | 118 | 15 | GO:0070848 |
| GeneOntologyBiologicalProcess | positive regulation of reactive oxygen species metabolic process | 1.59e-04 | 89 | 118 | 5 | GO:2000379 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 1.59e-04 | 89 | 118 | 5 | GO:0001523 | |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 1.81e-04 | 144 | 118 | 6 | GO:0006720 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 2.06e-04 | 94 | 118 | 5 | GO:0016101 | |
| GeneOntologyBiologicalProcess | aldehyde metabolic process | 2.16e-04 | 95 | 118 | 5 | GO:0006081 | |
| GeneOntologyBiologicalProcess | reactive oxygen species metabolic process | 2.73e-04 | 291 | 118 | 8 | GO:0072593 | |
| GeneOntologyBiologicalProcess | prostaglandin metabolic process | 2.97e-04 | 56 | 118 | 4 | GO:0006693 | |
| GeneOntologyBiologicalProcess | prostanoid metabolic process | 3.18e-04 | 57 | 118 | 4 | GO:0006692 | |
| GeneOntologyBiologicalProcess | regulation of filopodium assembly | 3.18e-04 | 57 | 118 | 4 | GO:0051489 | |
| GeneOntologyBiologicalProcess | ketone biosynthetic process | 3.18e-04 | 57 | 118 | 4 | GO:0042181 | |
| GeneOntologyBiologicalProcess | response to calcium ion | 3.30e-04 | 161 | 118 | 6 | GO:0051592 | |
| GeneOntologyBiologicalProcess | regulation of hormone metabolic process | 3.40e-04 | 58 | 118 | 4 | GO:0032350 | |
| GeneOntologyBiologicalProcess | neuron recognition | 3.63e-04 | 59 | 118 | 4 | GO:0008038 | |
| GeneOntologyBiologicalProcess | mesenchymal cell proliferation | 3.63e-04 | 59 | 118 | 4 | GO:0010463 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron migration | 3.83e-04 | 25 | 118 | 3 | GO:2001224 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell apoptotic process | 3.88e-04 | 60 | 118 | 4 | GO:1904037 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | 3.89e-04 | 387 | 118 | 9 | GO:0050807 | |
| GeneOntologyBiologicalProcess | negative regulation of cell projection organization | 3.91e-04 | 233 | 118 | 7 | GO:0031345 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 4.44e-04 | 313 | 118 | 8 | GO:0098742 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | EPHB2 CACNA1F NCKAP1 PLEKHG4 MYO10 USP9X SYNE1 GRHL2 SPAG6 TENM2 SEMA3A PTK2B BMP7 PTPRF PTPRZ1 PCDH15 ULK2 | 4.48e-04 | 1194 | 118 | 17 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | 4.51e-04 | 395 | 118 | 9 | GO:0050803 | |
| GeneOntologyBiologicalProcess | premeiotic DNA replication | 4.80e-04 | 6 | 118 | 2 | GO:0006279 | |
| GeneOntologyBiologicalProcess | neuron projection fasciculation | 5.39e-04 | 28 | 118 | 3 | GO:0106030 | |
| GeneOntologyBiologicalProcess | axonal fasciculation | 5.39e-04 | 28 | 118 | 3 | GO:0007413 | |
| GeneOntologyBiologicalProcess | secondary metabolic process | 5.91e-04 | 67 | 118 | 4 | GO:0019748 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | EPHB2 CACNA1F NCKAP1 PLEKHG4 USP9X SYNE1 SPAG6 TENM2 SEMA3A BMP7 PTPRF PTPRZ1 ULK2 | 6.82e-04 | 802 | 118 | 13 | GO:0048812 |
| GeneOntologyBiologicalProcess | dendrite development | 6.93e-04 | 335 | 118 | 8 | GO:0016358 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 7.29e-04 | 187 | 118 | 6 | GO:0007156 | |
| GeneOntologyBiologicalProcess | regulation of reactive oxygen species metabolic process | 7.50e-04 | 188 | 118 | 6 | GO:2000377 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 8.17e-04 | 73 | 118 | 4 | GO:1901616 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | EPHB2 CACNA1F NCKAP1 PLEKHG4 USP9X SYNE1 SPAG6 TENM2 SEMA3A BMP7 PTPRF PTPRZ1 ULK2 | 8.27e-04 | 819 | 118 | 13 | GO:0120039 |
| GeneOntologyBiologicalProcess | regulation of endothelial cell apoptotic process | 8.60e-04 | 74 | 118 | 4 | GO:2000351 | |
| GeneOntologyBiologicalProcess | regulation of mRNA splicing, via spliceosome | 8.81e-04 | 129 | 118 | 5 | GO:0048024 | |
| MousePheno | parturition failure | 3.03e-09 | 10 | 94 | 5 | MP:0012010 | |
| MousePheno | abnormal parturition | 7.53e-08 | 33 | 94 | 6 | MP:0002907 | |
| MousePheno | hypermyelination | 6.10e-07 | 11 | 94 | 4 | MP:0010050 | |
| MousePheno | increased oligodendrocyte number | 1.31e-06 | 13 | 94 | 4 | MP:0010160 | |
| MousePheno | increased circulating progesterone level | 2.47e-06 | 15 | 94 | 4 | MP:0005186 | |
| MousePheno | long stride length | 2.47e-06 | 15 | 94 | 4 | MP:0010540 | |
| MousePheno | long gestation period | 2.47e-06 | 15 | 94 | 4 | MP:0002293 | |
| MousePheno | abnormal gestational length | 5.46e-06 | 18 | 94 | 4 | MP:0002292 | |
| MousePheno | dysmyelination | 8.55e-06 | 20 | 94 | 4 | MP:0013438 | |
| MousePheno | decreased vocalization | 1.36e-05 | 46 | 94 | 5 | MP:0020351 | |
| MousePheno | decreased oligodendrocyte number | 2.18e-05 | 25 | 94 | 4 | MP:0009808 | |
| MousePheno | abnormal oligodendrocyte morphology | 2.27e-05 | 51 | 94 | 5 | MP:0000953 | |
| MousePheno | increased stereotypic behavior | 2.75e-05 | 53 | 94 | 5 | MP:0001409 | |
| MousePheno | prolonged diestrus | 4.60e-05 | 30 | 94 | 4 | MP:0009011 | |
| MousePheno | abnormal diestrus | 8.56e-05 | 35 | 94 | 4 | MP:0009010 | |
| MousePheno | respiratory system inflammation | 1.15e-04 | 220 | 94 | 8 | MP:0002405 | |
| MousePheno | enhanced coordination | 1.19e-04 | 38 | 94 | 4 | MP:0003858 | |
| MousePheno | prolonged estrous cycle | 1.32e-04 | 39 | 94 | 4 | MP:0009006 | |
| MousePheno | lung inflammation | 2.46e-04 | 185 | 94 | 7 | MP:0001861 | |
| MousePheno | abnormal circulating progesterone level | 3.48e-04 | 50 | 94 | 4 | MP:0005184 | |
| Domain | G2F | 2.52e-07 | 3 | 119 | 3 | SM00682 | |
| Domain | ALDOKETO_REDUCTASE_1 | 3.19e-07 | 10 | 119 | 4 | PS00798 | |
| Domain | ALDOKETO_REDUCTASE_2 | 3.19e-07 | 10 | 119 | 4 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 3.19e-07 | 10 | 119 | 4 | PS00063 | |
| Domain | Aldo/ket_reductase_CS | 3.19e-07 | 10 | 119 | 4 | IPR018170 | |
| Domain | Aldo/keto_reductase | 3.19e-07 | 10 | 119 | 4 | IPR020471 | |
| Domain | G2F | 1.00e-06 | 4 | 119 | 3 | PF07474 | |
| Domain | NIDOGEN_G2 | 1.00e-06 | 4 | 119 | 3 | PS50993 | |
| Domain | GFP | 1.00e-06 | 4 | 119 | 3 | IPR009017 | |
| Domain | G2_nidogen/fibulin_G2F | 1.00e-06 | 4 | 119 | 3 | IPR006605 | |
| Domain | - | 2.69e-06 | 16 | 119 | 4 | 3.20.20.100 | |
| Domain | NADP_OxRdtase_dom | 3.50e-06 | 17 | 119 | 4 | IPR023210 | |
| Domain | Aldo_ket_red | 3.50e-06 | 17 | 119 | 4 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 3.50e-06 | 17 | 119 | 4 | IPR001395 | |
| Domain | GFP-like | 4.01e-05 | 11 | 119 | 3 | IPR023413 | |
| Domain | - | 4.01e-05 | 11 | 119 | 3 | 2.40.155.10 | |
| Domain | PTPc | 7.88e-05 | 36 | 119 | 4 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 1.08e-04 | 39 | 119 | 4 | PS50055 | |
| Domain | K_chnl_volt-dep_ERG | 1.20e-04 | 3 | 119 | 2 | IPR003967 | |
| Domain | srGAP2 | 1.20e-04 | 3 | 119 | 2 | IPR030252 | |
| Domain | PTPase_domain | 1.32e-04 | 41 | 119 | 4 | IPR000242 | |
| Domain | Y_phosphatase | 1.32e-04 | 41 | 119 | 4 | PF00102 | |
| Domain | - | 1.61e-04 | 17 | 119 | 3 | 4.10.800.10 | |
| Domain | Thyroglobulin_1 | 1.61e-04 | 17 | 119 | 3 | IPR000716 | |
| Domain | THYROGLOBULIN_1_1 | 1.61e-04 | 17 | 119 | 3 | PS00484 | |
| Domain | TY | 1.61e-04 | 17 | 119 | 3 | SM00211 | |
| Domain | THYROGLOBULIN_1_2 | 1.61e-04 | 17 | 119 | 3 | PS51162 | |
| Domain | Thyroglobulin_1 | 1.61e-04 | 17 | 119 | 3 | PF00086 | |
| Domain | FN3 | 1.84e-04 | 185 | 119 | 7 | SM00060 | |
| Domain | FN3 | 2.87e-04 | 199 | 119 | 7 | PS50853 | |
| Domain | FN3_dom | 3.86e-04 | 209 | 119 | 7 | IPR003961 | |
| Domain | NIDO_dom | 3.98e-04 | 5 | 119 | 2 | IPR003886 | |
| Domain | NIDO | 3.98e-04 | 5 | 119 | 2 | SM00539 | |
| Domain | NIDO | 3.98e-04 | 5 | 119 | 2 | PF06119 | |
| Domain | NIDO | 3.98e-04 | 5 | 119 | 2 | PS51220 | |
| Domain | YD | 3.98e-04 | 5 | 119 | 2 | IPR006530 | |
| Domain | Growth_fac_rcpt_ | 4.92e-04 | 156 | 119 | 6 | IPR009030 | |
| Domain | PTPc_motif | 5.44e-04 | 59 | 119 | 4 | SM00404 | |
| Domain | Tyr_Pase_cat | 5.44e-04 | 59 | 119 | 4 | IPR003595 | |
| Domain | cEGF | 5.89e-04 | 26 | 119 | 3 | PF12662 | |
| Domain | cEGF | 5.89e-04 | 26 | 119 | 3 | IPR026823 | |
| Domain | MCM_N | 5.94e-04 | 6 | 119 | 2 | PF14551 | |
| Domain | MCM_CS | 5.94e-04 | 6 | 119 | 2 | IPR018525 | |
| Domain | MCM_N | 5.94e-04 | 6 | 119 | 2 | IPR027925 | |
| Domain | fn3 | 6.01e-04 | 162 | 119 | 6 | PF00041 | |
| Domain | - | EPHB2 CRLF2 PTPRT IGDCC4 SEMA3A FAM187B PTPRF HMCN1 PTPRG PTPRZ1 PXDNL CD200 | 1.08e-03 | 663 | 119 | 12 | 2.60.40.10 |
| Domain | Yippee/Mis18/Cereblon | 1.10e-03 | 8 | 119 | 2 | IPR004910 | |
| Domain | Yippee-Mis18 | 1.10e-03 | 8 | 119 | 2 | PF03226 | |
| Domain | MCM_OB | 1.10e-03 | 8 | 119 | 2 | PF17207 | |
| Domain | MCM_OB | 1.10e-03 | 8 | 119 | 2 | IPR033762 | |
| Domain | MCM_2 | 1.10e-03 | 8 | 119 | 2 | PS50051 | |
| Domain | MCM_1 | 1.10e-03 | 8 | 119 | 2 | PS00847 | |
| Domain | EGF_CA | 1.11e-03 | 122 | 119 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.19e-03 | 124 | 119 | 5 | IPR001881 | |
| Domain | Tyr_Pase_AS | 1.22e-03 | 73 | 119 | 4 | IPR016130 | |
| Domain | MCM | 1.41e-03 | 9 | 119 | 2 | SM00350 | |
| Domain | MCM_dom | 1.41e-03 | 9 | 119 | 2 | IPR001208 | |
| Domain | MCM | 1.41e-03 | 9 | 119 | 2 | IPR031327 | |
| Domain | MCM | 1.41e-03 | 9 | 119 | 2 | PF00493 | |
| Domain | PAS_9 | 1.75e-03 | 10 | 119 | 2 | PF13426 | |
| Domain | Ig-like_fold | EPHB2 CRLF2 PTPRT IGDCC4 SEMA3A FAM187B PTPRF HMCN1 PTPRG PTPRZ1 PXDNL CD200 | 1.83e-03 | 706 | 119 | 12 | IPR013783 |
| Domain | - | 1.95e-03 | 39 | 119 | 3 | 2.120.10.30 | |
| Domain | EGF_CA | 2.23e-03 | 86 | 119 | 4 | PF07645 | |
| Domain | TYR_PHOSPHATASE_1 | 2.23e-03 | 86 | 119 | 4 | PS00383 | |
| Domain | TYR_PHOSPHATASE_dom | 2.32e-03 | 87 | 119 | 4 | IPR000387 | |
| Domain | TYR_PHOSPHATASE_2 | 2.32e-03 | 87 | 119 | 4 | PS50056 | |
| Domain | EGF_dom | 2.55e-03 | 12 | 119 | 2 | IPR024731 | |
| Domain | ABC_A | 2.55e-03 | 12 | 119 | 2 | IPR026082 | |
| Domain | EGF_3 | 2.55e-03 | 12 | 119 | 2 | PF12947 | |
| Domain | - | 2.84e-03 | 92 | 119 | 4 | 3.90.190.10 | |
| Domain | P-loop_NTPase | ABCA4 ERCC6L ABCA12 MYO10 MCM2 NLRP1 MCM6 PFKFB2 DDX5 GUF1 KIF9 UCK2 HELLS | 2.93e-03 | 848 | 119 | 13 | IPR027417 |
| Domain | 6-blade_b-propeller_TolB-like | 3.14e-03 | 46 | 119 | 3 | IPR011042 | |
| Domain | EGF_Ca-bd_CS | 3.44e-03 | 97 | 119 | 4 | IPR018097 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 3.48e-03 | 14 | 119 | 2 | IPR003938 | |
| Domain | Ldl_recept_b | 3.48e-03 | 14 | 119 | 2 | PF00058 | |
| Domain | LDLRB | 3.48e-03 | 14 | 119 | 2 | PS51120 | |
| Domain | PH | 3.50e-03 | 229 | 119 | 6 | PF00169 | |
| Domain | EGF_CA | 3.70e-03 | 99 | 119 | 4 | PS01187 | |
| Domain | Prot-tyrosine_phosphatase-like | 3.70e-03 | 99 | 119 | 4 | IPR029021 | |
| Domain | ASX_HYDROXYL | 3.84e-03 | 100 | 119 | 4 | PS00010 | |
| Domain | LY | 4.00e-03 | 15 | 119 | 2 | SM00135 | |
| Domain | LDLR_classB_rpt | 4.00e-03 | 15 | 119 | 2 | IPR000033 | |
| Domain | Galactosyl_T | 4.56e-03 | 16 | 119 | 2 | PF01762 | |
| Domain | Glyco_trans_31 | 4.56e-03 | 16 | 119 | 2 | IPR002659 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 4.72e-03 | 106 | 119 | 4 | IPR000152 | |
| Domain | Carb_anhydrase | 5.14e-03 | 17 | 119 | 2 | PF00194 | |
| Domain | Carb_anhydrase | 5.14e-03 | 17 | 119 | 2 | SM01057 | |
| Domain | - | 5.14e-03 | 17 | 119 | 2 | 3.10.200.10 | |
| Domain | ALPHA_CA_2 | 5.14e-03 | 17 | 119 | 2 | PS51144 | |
| Domain | Carbonic_anhydrase_a | 5.14e-03 | 17 | 119 | 2 | IPR001148 | |
| Domain | PH_dom-like | 5.96e-03 | 426 | 119 | 8 | IPR011993 | |
| Pathway | WP_BENZOAPYRENE_METABOLISM | 1.83e-07 | 9 | 89 | 4 | M39344 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY | 1.83e-07 | 9 | 89 | 4 | M47817 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM | 4.74e-07 | 11 | 89 | 4 | M47812 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 1.02e-06 | 13 | 89 | 4 | M17842 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL | 1.02e-06 | 13 | 89 | 4 | MM14747 | |
| Pathway | WP_GLUCOCORTICOID_BIOSYNTHESIS | 1.42e-06 | 14 | 89 | 4 | M46449 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 1.42e-06 | 14 | 89 | 4 | M27074 | |
| Pathway | WP_MINERALOCORTICOID_BIOSYNTHESIS | 1.42e-06 | 14 | 89 | 4 | M46453 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 1.42e-06 | 14 | 89 | 4 | MM14748 | |
| Pathway | REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX | 1.92e-06 | 15 | 89 | 4 | MM14870 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 8.97e-06 | 45 | 89 | 5 | MM15344 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 1.20e-05 | 23 | 89 | 4 | M1926 | |
| Pathway | REACTOME_PREDNISONE_ADME | 1.20e-05 | 23 | 89 | 4 | MM16639 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL | 1.20e-05 | 23 | 89 | 4 | MM14741 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 2.46e-05 | 92 | 89 | 6 | MM14881 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 2.71e-05 | 28 | 89 | 4 | MM15188 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 5.28e-05 | 33 | 89 | 4 | M5967 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 5.28e-05 | 33 | 89 | 4 | MM14737 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 1.66e-04 | 44 | 89 | 4 | M499 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 1.81e-04 | 45 | 89 | 4 | MM14751 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 2.34e-04 | 48 | 89 | 4 | M27642 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 2.53e-04 | 49 | 89 | 4 | MM15186 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | 3.96e-04 | 55 | 89 | 4 | M14933 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 4.21e-04 | 100 | 89 | 5 | M27158 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DNA_REPLICATION_LICENSING | 4.47e-04 | 24 | 89 | 3 | M47857 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 5.89e-04 | 61 | 89 | 4 | MM14861 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 9.91e-04 | 70 | 89 | 4 | M16794 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX | 1.06e-03 | 32 | 89 | 3 | MM15368 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BREAK_INDUCED_REPLICATION | 1.08e-03 | 8 | 89 | 2 | M47840 | |
| Pathway | PID_INTEGRIN_A4B1_PATHWAY | 1.16e-03 | 33 | 89 | 3 | M277 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX | 1.16e-03 | 33 | 89 | 3 | M9694 | |
| Pathway | REACTOME_SENSORY_PERCEPTION | 1.27e-03 | 190 | 89 | 6 | MM15687 | |
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 20124700 | ||
| Pubmed | Structure and activity of the murine type 5 17beta-hydroxysteroid dehydrogenase gene(1). | 1.54e-10 | 4 | 124 | 4 | 10500239 | |
| Pubmed | Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family. | 1.54e-10 | 4 | 124 | 4 | 16508162 | |
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 19487289 | ||
| Pubmed | Cloning and chromosomal localization of mouse 20alpha-hydroxysteroid dehydrogenase gene. | 1.54e-10 | 4 | 124 | 4 | 14967952 | |
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 10393440 | ||
| Pubmed | Localization of 20alpha-hydroxysteroid dehydrogenase mRNA in mouse brain by in situ hybridization. | 1.54e-10 | 4 | 124 | 4 | 15193432 | |
| Pubmed | Mouse Akr1cl gene product is a prostaglandin D2 11-ketoreductase with strict substrate specificity. | 1.54e-10 | 4 | 124 | 4 | 31479646 | |
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 15222881 | ||
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 16191478 | ||
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 15577209 | ||
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 10702227 | ||
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 17034817 | ||
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 17629694 | ||
| Pubmed | RECON-Dependent Inflammation in Hepatocytes Enhances Listeria monocytogenes Cell-to-Cell Spread. | 1.54e-10 | 4 | 124 | 4 | 29764944 | |
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 10526179 | ||
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 17888864 | ||
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 17442338 | ||
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 28329705 | ||
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 16018803 | ||
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 17272929 | ||
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 19237748 | ||
| Pubmed | Involvement of 20alpha-hydroxysteroid dehydrogenase in the maintenance of pregnancy in mice. | 1.54e-10 | 4 | 124 | 4 | 18667791 | |
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 28259989 | ||
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 21521174 | ||
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 8274401 | ||
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 16511129 | ||
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 10803568 | ||
| Pubmed | AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway. | 1.54e-10 | 4 | 124 | 4 | 34590152 | |
| Pubmed | 1.54e-10 | 4 | 124 | 4 | 7789999 | ||
| Pubmed | 7.67e-10 | 5 | 124 | 4 | 7737980 | ||
| Pubmed | Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily. | 7.67e-10 | 5 | 124 | 4 | 21851338 | |
| Pubmed | 7.67e-10 | 5 | 124 | 4 | 17872381 | ||
| Pubmed | Mouse 3alpha-hydroxysteroid dehydrogenase mRNA: a marker of lung maturity. | 7.67e-10 | 5 | 124 | 4 | 17064890 | |
| Pubmed | 7.67e-10 | 5 | 124 | 4 | 10672042 | ||
| Pubmed | 7.67e-10 | 5 | 124 | 4 | 38788959 | ||
| Pubmed | Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. | 7.67e-10 | 5 | 124 | 4 | 16984997 | |
| Pubmed | 7.67e-10 | 5 | 124 | 4 | 18003893 | ||
| Pubmed | The Gαq/11-provoked induction of Akr1c18 in murine luteal cells is mediated by phospholipase C. | 2.30e-09 | 6 | 124 | 4 | 29107092 | |
| Pubmed | 2.30e-09 | 6 | 124 | 4 | 19273550 | ||
| Pubmed | 2.30e-09 | 6 | 124 | 4 | 15860270 | ||
| Pubmed | 2.30e-09 | 6 | 124 | 4 | 15471942 | ||
| Pubmed | MEF2 and NR2F2 cooperate to regulate Akr1c14 gene expression in mouse MA-10 Leydig cells. | 2.30e-09 | 6 | 124 | 4 | 26748576 | |
| Pubmed | 2.30e-09 | 6 | 124 | 4 | 17122075 | ||
| Pubmed | Decidual prolactin silences the expression of genes detrimental to pregnancy. | 2.30e-09 | 6 | 124 | 4 | 17255200 | |
| Pubmed | 5.34e-09 | 7 | 124 | 4 | 26160177 | ||
| Pubmed | Aldo-ketoreductase 1c19 ablation does not affect insulin secretion in murine islets. | 5.34e-09 | 7 | 124 | 4 | 34843575 | |
| Pubmed | 5.34e-09 | 7 | 124 | 4 | 22529366 | ||
| Pubmed | 5.34e-09 | 7 | 124 | 4 | 33127481 | ||
| Pubmed | 5.34e-09 | 7 | 124 | 4 | 12562828 | ||
| Pubmed | 5.34e-09 | 7 | 124 | 4 | 16337335 | ||
| Pubmed | 1.07e-08 | 8 | 124 | 4 | 33584538 | ||
| Pubmed | 1.07e-08 | 8 | 124 | 4 | 20837989 | ||
| Pubmed | 1.07e-08 | 8 | 124 | 4 | 9224647 | ||
| Pubmed | 1.91e-08 | 9 | 124 | 4 | 33348080 | ||
| Pubmed | Lack of placental neurosteroid alters cortical development and female somatosensory function. | 3.18e-08 | 10 | 124 | 4 | 36313771 | |
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 19320734 | ||
| Pubmed | Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis. | 4.42e-08 | 3 | 124 | 3 | 31780644 | |
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 7626489 | ||
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 21232532 | ||
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 13678667 | ||
| Pubmed | Endogenous biotin as a marker of adrenocortical cells with steroidogenic potential. | 7.45e-08 | 12 | 124 | 4 | 21256921 | |
| Pubmed | Timing of adrenal regression controlled by synergistic interaction between Sf1 SUMOylation and Dax1. | 7.45e-08 | 12 | 124 | 4 | 28893949 | |
| Pubmed | 7.45e-08 | 12 | 124 | 4 | 25774556 | ||
| Pubmed | 1.07e-07 | 13 | 124 | 4 | 11682476 | ||
| Pubmed | 1.07e-07 | 13 | 124 | 4 | 17062636 | ||
| Pubmed | A link between lung androgen metabolism and the emergence of mature epithelial type II cells. | 1.07e-07 | 13 | 124 | 4 | 15117747 | |
| Pubmed | 1.07e-07 | 13 | 124 | 4 | 24580729 | ||
| Pubmed | 1.50e-07 | 14 | 124 | 4 | 19955443 | ||
| Pubmed | Placental endocrine function shapes cerebellar development and social behavior. | 1.50e-07 | 14 | 124 | 4 | 34400844 | |
| Pubmed | 3.53e-07 | 17 | 124 | 4 | 32243503 | ||
| Pubmed | 4.40e-07 | 5 | 124 | 3 | 15212687 | ||
| Pubmed | Functional dynamics of H3K9 methylation during meiotic prophase progression. | 5.72e-07 | 19 | 124 | 4 | 17599069 | |
| Pubmed | 7.13e-07 | 20 | 124 | 4 | 23636947 | ||
| Pubmed | 7.13e-07 | 20 | 124 | 4 | 24135228 | ||
| Pubmed | 1.29e-06 | 23 | 124 | 4 | 23685333 | ||
| Pubmed | Genome-wide association study identifies five new schizophrenia loci. | 1.29e-06 | 23 | 124 | 4 | 21926974 | |
| Pubmed | 1.53e-06 | 7 | 124 | 3 | 19846565 | ||
| Pubmed | 1.84e-06 | 25 | 124 | 4 | 26098214 | ||
| Pubmed | Histone H3 lysine 9 methyltransferases, G9a and GLP are essential for cardiac morphogenesis. | 2.17e-06 | 26 | 124 | 4 | 23892084 | |
| Pubmed | 2.45e-06 | 8 | 124 | 3 | 16899510 | ||
| Pubmed | 2.53e-06 | 27 | 124 | 4 | 17077188 | ||
| Pubmed | Identification of differentially expressed genes in mouse spermatogenesis. | 2.53e-06 | 27 | 124 | 4 | 14581517 | |
| Pubmed | 2.53e-06 | 27 | 124 | 4 | 23471215 | ||
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 2.85e-06 | 171 | 124 | 7 | 20201926 | |
| Pubmed | MRAP deficiency impairs adrenal progenitor cell differentiation and gland zonation. | 2.95e-06 | 28 | 124 | 4 | 29879378 | |
| Pubmed | 2.95e-06 | 28 | 124 | 4 | 21820362 | ||
| Pubmed | The E3 ubiquitin ligase Siah1 regulates adrenal gland organization and aldosterone secretion. | 2.95e-06 | 28 | 124 | 4 | 29212953 | |
| Pubmed | 3.66e-06 | 9 | 124 | 3 | 10846177 | ||
| Pubmed | 5.12e-06 | 32 | 124 | 4 | 34288113 | ||
| Pubmed | EPHB2 PLEKHG4 DGKH IDE PFKFB2 NUP58 ITPRID1 GRHL2 PTPRZ1 PXDNL CSNK2A2 AKR1C3 | 6.72e-06 | 686 | 124 | 12 | 29987050 | |
| Pubmed | Loss of nidogen-1 and -2 results in syndactyly and changes in limb development. | 7.15e-06 | 11 | 124 | 3 | 17023412 | |
| Pubmed | 9.28e-06 | 37 | 124 | 4 | 21362171 | ||
| Pubmed | 1.17e-05 | 390 | 124 | 9 | 17643375 | ||
| Pubmed | Interactions of the human MCM-BP protein with MCM complex components and Dbf4. | 1.23e-05 | 13 | 124 | 3 | 22540012 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 8172617 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 8573067 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 7650035 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 11514561 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 22623588 | ||
| Interaction | AKR1C4 interactions | 8.22e-08 | 8 | 120 | 4 | int:AKR1C4 | |
| Interaction | AKR1C1 interactions | 5.38e-06 | 20 | 120 | 4 | int:AKR1C1 | |
| Cytoband | 10p15-p14 | 3.82e-07 | 6 | 124 | 3 | 10p15-p14 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10p15 | 1.08e-04 | 90 | 124 | 4 | chr10p15 | |
| GeneFamily | Aldo-keto reductases | 5.97e-07 | 15 | 85 | 4 | 399 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 2.56e-06 | 21 | 85 | 4 | 813 | |
| GeneFamily | Fibronectin type III domain containing | 1.03e-05 | 160 | 85 | 7 | 555 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 4.21e-04 | 206 | 85 | 6 | 682 | |
| GeneFamily | MCM family | 7.70e-04 | 9 | 85 | 2 | 1085 | |
| GeneFamily | ATP binding cassette subfamily A | 1.92e-03 | 14 | 85 | 2 | 805 | |
| GeneFamily | Cadherin related | 2.84e-03 | 17 | 85 | 2 | 24 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.71e-03 | 66 | 85 | 3 | 722 | |
| GeneFamily | Rho GTPase activating proteins|F-BAR domain containing | 5.18e-03 | 23 | 85 | 2 | 1288 | |
| GeneFamily | Beta 3-glycosyltransferases | 5.64e-03 | 24 | 85 | 2 | 426 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 7.01e-03 | 161 | 85 | 4 | 593 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3 | 1.10e-10 | 79 | 121 | 9 | MM535 | |
| Coexpression | WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP | 7.47e-07 | 37 | 121 | 5 | MM630 | |
| Coexpression | GOLDRATH_IMMUNE_MEMORY | 8.08e-07 | 69 | 121 | 6 | MM621 | |
| Coexpression | RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP | 8.46e-07 | 219 | 121 | 9 | MM1237 | |
| Coexpression | IRITANI_MAD1_TARGETS_UP | 9.82e-07 | 17 | 121 | 4 | MM826 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3 | 1.22e-06 | 74 | 121 | 6 | M1277 | |
| Coexpression | VARELA_ZMPSTE24_TARGETS_DN | 2.03e-06 | 45 | 121 | 5 | MM1173 | |
| Coexpression | GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_UP | 3.57e-06 | 195 | 121 | 8 | M8006 | |
| Coexpression | LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK | 4.27e-06 | 24 | 121 | 4 | MM766 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN | 5.07e-06 | 25 | 121 | 4 | MM480 | |
| Coexpression | BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS | 1.08e-05 | 30 | 121 | 4 | MM853 | |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_B | TMEM67 NID2 ABCA4 B3GNT5 SDCCAG8 AKR1C4 AKR1C1 AKR1C2 MTUS1 DBF4 CCDC68 AKR1C3 | 1.72e-05 | 584 | 121 | 12 | MM1080 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_INTERMEDIATE_LYMPHATIC_ENDO_CELL | EPHB2 ABCA4 MAN1A1 SYNE1 CCDC122 AKR1C1 AKR1C2 SEMA3A AKR1C3 ULK2 | 1.80e-05 | 402 | 121 | 10 | M45754 |
| Coexpression | DESCARTES_ORGANOGENESIS_INTERMEDIATE_MESODERM | 2.27e-05 | 36 | 121 | 4 | MM3660 | |
| Coexpression | BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP | 2.41e-05 | 74 | 121 | 5 | MM769 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 3.47e-05 | 40 | 121 | 4 | M5887 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1 | 3.87e-05 | 440 | 121 | 10 | M39039 | |
| Coexpression | GSE28783_ANTI_MIR33_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_DN | 3.98e-05 | 199 | 121 | 7 | M8352 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDC_DN | 4.11e-05 | 200 | 121 | 7 | M3973 | |
| Coexpression | GSE17721_0.5H_VS_24H_CPG_BMDC_DN | 4.11e-05 | 200 | 121 | 7 | M4129 | |
| Coexpression | GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_DN | 4.11e-05 | 200 | 121 | 7 | M5603 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | CUL4B MCM2 MCM6 IDE YWHAZ GUF1 DBF4 GOLGA7 UCK2 PACC1 SRGAP2B HELLS | 4.47e-05 | 644 | 121 | 12 | M10501 |
| Coexpression | RAO_BOUND_BY_SALL4_ISOFORM_A | 5.59e-05 | 210 | 121 | 7 | MM958 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP | EPHB2 TMEM67 B3GNT5 ERCC6L EML6 MECOM MCM6 SPAG6 IGDCC4 KCNH6 GPC3 PTPRG ODAM PACC1 | 6.47e-05 | 891 | 121 | 14 | M45033 |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_UP | NSUN4 MCM6 CAT AKR1C4 IDE SMOC2 AKR1C1 AKR1C2 PTPRF PTPRG PTPRZ1 AKR1C3 | 8.50e-05 | 689 | 121 | 12 | MM1041 |
| Coexpression | INGRAM_SHH_TARGETS_UP | 8.83e-05 | 156 | 121 | 6 | MM550 | |
| Coexpression | MARTINEZ_TP53_TARGETS_UP | NSUN4 MCM6 CAT AKR1C4 IDE SMOC2 AKR1C1 AKR1C2 PTPRF PTPRG PTPRZ1 AKR1C3 | 9.10e-05 | 694 | 121 | 12 | MM1039 |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6 | 1.12e-04 | 102 | 121 | 5 | MM872 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | DOCK1 NID2 FAT4 B3GNT5 RASGRF2 MYO10 MECOM SMOC2 ARHGEF17 GRHL2 BMP7 ANTXR2 GPC3 HMCN1 MTUS1 | 1.30e-04 | 1074 | 121 | 15 | M1941 |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 1.37e-04 | 169 | 121 | 6 | M39230 | |
| Coexpression | DESCARTES_FETAL_THYMUS_THYMIC_EPITHELIAL_CELLS | 1.43e-04 | 244 | 121 | 7 | M40312 | |
| Coexpression | WOOD_EBV_EBNA1_TARGETS_UP | 1.60e-04 | 110 | 121 | 5 | M1696 | |
| Coexpression | ZHENG_GLIOBLASTOMA_PLASTICITY_UP | 1.62e-04 | 249 | 121 | 7 | M1796 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | NID2 MAN1A1 RASA2 MYO10 USP9X DGKH TENM2 PTPRG MTUS1 YPEL5 MED12L NID1 ULK2 | 1.64e-04 | 854 | 121 | 13 | M1533 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | MAN1A1 RASA2 USP9X SYNE1 NLRP1 PSME2 YWHAZ DDX5 PTK2B RGS14 ZNF800 ANTXR2 PELO GOLGA7 YPEL5 GAB3 CRBN SENP7 | 1.69e-04 | 1492 | 121 | 18 | M40023 |
| Coexpression | MARSON_FOXP3_TARGETS_DN | 1.73e-04 | 60 | 121 | 4 | MM847 | |
| Coexpression | HEVNER_CORTEX_RADIAL_GLIA_PROGENITORS | 1.83e-04 | 432 | 121 | 9 | MM419 | |
| Coexpression | IBRAHIM_NRF2_UP | NCKAP1 B3GALNT2 IDE AKR1C1 AKR1C2 PELO CSNK2A2 AKR1C3 UCK2 PACC1 | 1.87e-04 | 533 | 121 | 10 | M42510 |
| Coexpression | ZHENG_GLIOBLASTOMA_PLASTICITY_UP | 1.96e-04 | 257 | 121 | 7 | MM1231 | |
| Coexpression | DEN_INTERACT_WITH_LCA5 | 2.31e-04 | 26 | 121 | 3 | M1380 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CUL4B MYO10 USP9X THUMPD3 BMP7 MTUS1 WASHC5 DBF4 NID1 DNAJC1 HELLS | 2.35e-04 | 656 | 121 | 11 | M18979 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | NID2 MAN1A1 RASA2 MYO10 USP9X DGKH TENM2 PTPRG MTUS1 YPEL5 MED12L NID1 ULK2 | 2.39e-04 | 888 | 121 | 13 | MM1018 |
| Coexpression | NADLER_HYPERGLYCEMIA_AT_OBESITY | 2.50e-04 | 66 | 121 | 4 | MM631 | |
| Coexpression | SERVITJA_ISLET_HNF1A_TARGETS_DN | 2.50e-04 | 121 | 121 | 5 | MM935 | |
| Coexpression | DARWICHE_PAPILLOMA_RISK_LOW_UP | 2.73e-04 | 192 | 121 | 6 | MM497 | |
| Coexpression | NABA_CORE_MATRISOME | 2.96e-04 | 275 | 121 | 7 | M5884 | |
| Coexpression | ENGELMANN_CANCER_PROGENITORS_DN | 2.96e-04 | 69 | 121 | 4 | M9246 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 3.02e-04 | 276 | 121 | 7 | M3063 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.05e-04 | 196 | 121 | 6 | M3008 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_EPITHELIAL_CELL_AGEING | MYO10 COBLL1 CAT AKR1C4 GRHL2 AKR1C1 AKR1C2 WASHC5 AKR1C3 DMBT1 | 3.11e-04 | 568 | 121 | 10 | MM3824 |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN | 3.15e-04 | 465 | 121 | 9 | M9192 | |
| Coexpression | VALK_AML_CLUSTER_1 | 3.21e-04 | 29 | 121 | 3 | M19844 | |
| Coexpression | GSE17721_LPS_VS_PAM3CSK4_4H_BMDC_UP | 3.31e-04 | 199 | 121 | 6 | M3915 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP | 3.31e-04 | 199 | 121 | 6 | M7420 | |
| Coexpression | GSE21063_WT_VS_NFATC1_KO_3H_ANTI_IGM_STIM_BCELL_DN | 3.40e-04 | 200 | 121 | 6 | M8253 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_COMMON_LYMPHOID_PROGENITOR_DN | 3.40e-04 | 200 | 121 | 6 | M8854 | |
| Coexpression | GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_MINERALCORTICOID_REC_KO_UP | 3.40e-04 | 200 | 121 | 6 | M7746 | |
| Coexpression | GSE21360_SECONDARY_VS_TERTIARY_MEMORY_CD8_TCELL_UP | 3.40e-04 | 200 | 121 | 6 | M7611 | |
| Coexpression | GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TREG_DN | 3.40e-04 | 200 | 121 | 6 | M8962 | |
| Coexpression | GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_UP | 3.40e-04 | 200 | 121 | 6 | M9051 | |
| Coexpression | ONDER_CDH1_TARGETS_2_DN | 3.57e-04 | 473 | 121 | 9 | M4306 | |
| Coexpression | RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP | 3.78e-04 | 204 | 121 | 6 | M1844 | |
| Coexpression | BROWN_MYELOID_CELL_DEVELOPMENT_DN | 4.59e-04 | 138 | 121 | 5 | MM1151 | |
| Coexpression | LI_CISPLATIN_RESISTANCE_DN | 4.73e-04 | 33 | 121 | 3 | M10150 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_SCG3_POS_LYMPHATIC_ENDOTHELIAL_CELL | ABCA4 ANK2 B3GNT5 SYNE1 IDE AKR1C1 AKR1C2 SEMA3A PTPRF AKR1C3 | 5.02e-04 | 604 | 121 | 10 | M45760 |
| Coexpression | HUANG_DASATINIB_SENSITIVITY_UP | 5.21e-04 | 80 | 121 | 4 | M3015 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_UP | 5.39e-04 | 143 | 121 | 5 | MM989 | |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_top-relative-expression-ranked_200 | 1.98e-05 | 145 | 121 | 7 | gudmap_kidney_e10.5_UretericTip_HoxB7_200 | |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_top-relative-expression-ranked_100 | 3.74e-05 | 66 | 121 | 5 | gudmap_kidney_e10.5_UretericTip_HoxB7_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | DOCK1 CUL4B MYO10 USP9X SDCCAG8 IDE PFKFB2 NUP58 GRHL2 MED12L | 5.82e-05 | 375 | 121 | 10 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_top-relative-expression-ranked_500 | ERCC6L COBLL1 MECOM GRHL2 CLDN8 SEMA3A GPC3 HMCN1 PTPRZ1 HELLS | 7.09e-05 | 384 | 121 | 10 | gudmap_kidney_e10.5_UretericTip_HoxB7_500 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-08 | 176 | 124 | 8 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 6.07e-08 | 189 | 124 | 8 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.32e-08 | 190 | 124 | 8 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 7.14e-08 | 193 | 124 | 8 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.04e-08 | 196 | 124 | 8 | ed818de15f84f7f28bd06fd69d7876710da232a0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.36e-08 | 197 | 124 | 8 | 62c0a90869431e582bb7bb329e0b0cc59123d3d1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.36e-08 | 197 | 124 | 8 | 16f0eb047df9d702518f82ee99c6e7dc1350b2fb | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.03e-08 | 199 | 124 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.03e-08 | 199 | 124 | 8 | 63c01e8961f48ed1bed4ab619cacf318cd6de7b9 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-07 | 160 | 124 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-07 | 160 | 124 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.62e-07 | 177 | 124 | 7 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.41e-07 | 180 | 124 | 7 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L3-4_RORB_RPS3P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.90e-07 | 185 | 124 | 7 | 10da5c2a92bfb3248d3f6f94a0933996326cf590 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Airway_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.03e-06 | 189 | 124 | 7 | 4f9608b84d135268a17455661870c46ae8554a24 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.06e-06 | 190 | 124 | 7 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 191 | 124 | 7 | 5a5b5402a077b3189ca156f2bac5f47ad780aebf | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 191 | 124 | 7 | 78bcce497920cc5b3bef083eab50deb1cc82cd2e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-06 | 191 | 124 | 7 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.10e-06 | 191 | 124 | 7 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_BHLHE22|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.14e-06 | 192 | 124 | 7 | 25460ca9ebd3d49f666394cf99ab77a5e8f77250 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.18e-06 | 193 | 124 | 7 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.18e-06 | 193 | 124 | 7 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.22e-06 | 194 | 124 | 7 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-06 | 194 | 124 | 7 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-06 | 194 | 124 | 7 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.22e-06 | 194 | 124 | 7 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.22e-06 | 194 | 124 | 7 | ea5e1bc8d9e27cabfe1fb833ca47ec0893593b12 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.22e-06 | 194 | 124 | 7 | cceb7c88492bb6cd531e1c2651638da1ddf30931 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-06 | 194 | 124 | 7 | 1374600957c7d7f0b05fd2c1186f521b9096d4ef | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.27e-06 | 195 | 124 | 7 | a38d9dc6192aea673d96fda6b25e81223fda3abf | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.27e-06 | 195 | 124 | 7 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.40e-06 | 198 | 124 | 7 | 0a4626b51ba8b52acbaf616f0ced850079cd7149 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.40e-06 | 198 | 124 | 7 | a4543d636501a1b5b46c14a661ce9d169947c82c | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-epithelial_progenitor_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.40e-06 | 198 | 124 | 7 | e8bfae3888b2406b5629b576cb02913b3297337e | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.45e-06 | 199 | 124 | 7 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.45e-06 | 199 | 124 | 7 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.50e-06 | 200 | 124 | 7 | 86ec951234015ced7126b016199e5869a0f22478 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.50e-06 | 200 | 124 | 7 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.50e-06 | 200 | 124 | 7 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_capilar|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.50e-06 | 200 | 124 | 7 | c239e6f5d23caa9a59b83e9b352b2d6a691dcb28 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.50e-06 | 200 | 124 | 7 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-HSC/MPP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 6.03e-06 | 161 | 124 | 6 | 46b5d80d2d521fb69752aba4c10383e715a32002 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.18e-06 | 166 | 124 | 6 | 89e2b8453180983533faccb4275867861876d7ee | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.95e-06 | 169 | 124 | 6 | 335619507857383c3b0b507cdf05d786ed59e585 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.09e-06 | 173 | 124 | 6 | 9a2d42f8d9cb834856522661d524abb91c4637c5 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.71e-06 | 175 | 124 | 6 | ff0789f5913c9f3c49159e40b1ec3d2ff175ec9f | |
| ToppCell | systemic_lupus_erythematosus-flare-Myeloid-conventional_dendritic_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.71e-06 | 175 | 124 | 6 | c58a1f02d1e559d3638fe1500e960e82a8a7187b | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 9.71e-06 | 175 | 124 | 6 | 21f8f11a8b874d4f7c47931010a2535f2a5a3373 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-05 | 177 | 124 | 6 | 3d955ea938a1d2fb1b6d68d4997fd454bd632dfc | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.04e-05 | 177 | 124 | 6 | 2dd6dd5193bda9ba1c6b299ec47890fdc92f88b1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.07e-05 | 178 | 124 | 6 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-05 | 179 | 124 | 6 | 8766a5a066091879f521acfc612abf563ff78808 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-05 | 180 | 124 | 6 | 280ff5c8f292be1b88120db5ff1788b750644856 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-05 | 180 | 124 | 6 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-05 | 180 | 124 | 6 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-05 | 181 | 124 | 6 | 9d782ba5cf5a172cb4f447763fc50e5b13ef7dd9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-05 | 181 | 124 | 6 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.18e-05 | 181 | 124 | 6 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-05 | 181 | 124 | 6 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-05 | 182 | 124 | 6 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 183 | 124 | 6 | 83592c332b1e82673f993d37c7f480befdc3dcda | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.25e-05 | 183 | 124 | 6 | 6c1d7ce60e67bf1df364a4e177c351e7313eb41f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 184 | 124 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 184 | 124 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-05 | 184 | 124 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.33e-05 | 185 | 124 | 6 | 47c69500877b851c0c9744f5e1ef2ee0bff99168 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.33e-05 | 185 | 124 | 6 | 241ea1e178fffef9e7df971de739e794332d5173 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-05 | 186 | 124 | 6 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.41e-05 | 187 | 124 | 6 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.41e-05 | 187 | 124 | 6 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.41e-05 | 187 | 124 | 6 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-05 | 187 | 124 | 6 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-Cd36+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-05 | 188 | 124 | 6 | e901a9bdf00b8e91806f445af66647373bf62661 | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial-endothelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-05 | 188 | 124 | 6 | 5cf060bb8adaefa9964187195d67993c1248ef47 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 1.46e-05 | 188 | 124 | 6 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-05 | 188 | 124 | 6 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-05 | 188 | 124 | 6 | e30a4ddac0da8cdcf621d98e28e3895cd9307e7a | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-05 | 188 | 124 | 6 | 14e120b20e76baa07b6510a94f0c2dcdfdd52357 | |
| ToppCell | droplet-Fat-SCAT-30m-Endothelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-05 | 188 | 124 | 6 | 449f9602df3c83b2110eb479a00d428d1b55b423 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-05 | 189 | 124 | 6 | 443359d90fafae0c1de6bdcce9e8c95df6ea4de8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 189 | 124 | 6 | bfc76a72b600d641c8fe58346e5d8986c34f3981 | |
| ToppCell | COVID-19-Heart-EC_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.50e-05 | 189 | 124 | 6 | fe49852ba15f948b384d6b4c258927c70b741357 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.50e-05 | 189 | 124 | 6 | 9c2492c38f27e4c699b40680652e4c64911cce52 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-05 | 189 | 124 | 6 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 190 | 124 | 6 | 1cf023e3c6924d6a06f353d4b62444b6f2fee8a7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 190 | 124 | 6 | bf4511395fa97efd1c1cd17cc9bebb0271ee7f0e | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 1.55e-05 | 190 | 124 | 6 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 190 | 124 | 6 | b6b8964b4910083499681b5fdf554e127b6a4c4e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 190 | 124 | 6 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.55e-05 | 190 | 124 | 6 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.55e-05 | 190 | 124 | 6 | 0e9847d7f49b2236b8a191e1a7df37556351ba9e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 190 | 124 | 6 | 11d3c31167ea71809b4cc3757a0c6ea54a448602 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.55e-05 | 190 | 124 | 6 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 190 | 124 | 6 | b7f8c2bb9459f1d7c1690069dd5a25a81a57cc84 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 1.55e-05 | 190 | 124 | 6 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-05 | 191 | 124 | 6 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-05 | 191 | 124 | 6 | 2fa1b9e76a0ed2d2f0de74349e266cf4a5f51aad | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.59e-05 | 191 | 124 | 6 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.59e-05 | 191 | 124 | 6 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| Computational | Intermediate filaments. | 2.05e-04 | 75 | 78 | 5 | MODULE_154 | |
| Computational | Intermediate filaments and keratins. | 2.78e-04 | 80 | 78 | 5 | MODULE_357 | |
| Computational | Genes in the cancer module 297. | 2.78e-04 | 80 | 78 | 5 | MODULE_297 | |
| Drug | cloxazolam | 7.85e-10 | 4 | 122 | 4 | ctd:C005522 | |
| Drug | Pregnanes | 7.85e-10 | 4 | 122 | 4 | ctd:D011278 | |
| Drug | tetralol | 7.85e-10 | 4 | 122 | 4 | ctd:C019106 | |
| Drug | 3',3'',5',5''-tetrabromophenolphthalein | 7.85e-10 | 4 | 122 | 4 | ctd:C018156 | |
| Drug | octyl gallate | 1.00e-09 | 10 | 122 | 5 | ctd:C016627 | |
| Drug | Hydroxysteroids | 3.91e-09 | 5 | 122 | 4 | ctd:D006914 | |
| Drug | cresolphthalein | 3.91e-09 | 5 | 122 | 4 | ctd:C010092 | |
| Drug | Medazepam | 1.17e-08 | 6 | 122 | 4 | ctd:D008472 | |
| Drug | Nitrazepam | 5.40e-08 | 8 | 122 | 4 | ctd:D009567 | |
| Drug | 4-hydroxybenzoic acid | 9.68e-08 | 9 | 122 | 4 | ctd:C038193 | |
| Drug | 20-alpha-Dihydroprogesterone | 9.68e-08 | 9 | 122 | 4 | ctd:D004092 | |
| Drug | cyclopentanol | 1.50e-07 | 3 | 122 | 3 | ctd:C016327 | |
| Drug | cyclopentanone | 1.50e-07 | 3 | 122 | 3 | ctd:C007201 | |
| Drug | 5-dihydrodeoxycorticosterone | 1.50e-07 | 3 | 122 | 3 | ctd:C454687 | |
| Drug | 4-benzoylbenzoic acid | 1.50e-07 | 3 | 122 | 3 | ctd:C058818 | |
| Drug | dichloro(4-cymene)ruthenium(II) | 1.50e-07 | 3 | 122 | 3 | ctd:C530610 | |
| Drug | Glycyrrhetinic Acid | 1.59e-07 | 24 | 122 | 5 | ctd:D006034 | |
| Drug | Dihydroxydihydrobenzopyrenes | 2.52e-07 | 11 | 122 | 4 | ctd:D004101 | |
| Drug | chlordecone alcohol | 2.52e-07 | 11 | 122 | 4 | CID000013946 | |
| Drug | Phenolphthalein | 3.76e-07 | 12 | 122 | 4 | ctd:D020113 | |
| Drug | DMBA-3,4-dihydrodiol | 5.40e-07 | 13 | 122 | 4 | CID000050096 | |
| Drug | flunisolide | 5.40e-07 | 13 | 122 | 4 | ctd:C007734 | |
| Drug | tetrahydrodeoxycorticosterone | 5.98e-07 | 4 | 122 | 3 | ctd:C009413 | |
| Drug | gliquidone | 5.98e-07 | 4 | 122 | 3 | ctd:C010969 | |
| Drug | DBD-H | 5.98e-07 | 4 | 122 | 3 | CID000131382 | |
| Drug | 5-alpha-Dihydroprogesterone | 7.54e-07 | 14 | 122 | 4 | ctd:D043582 | |
| Drug | 1-acenaphthenol | 7.54e-07 | 14 | 122 | 4 | CID000022750 | |
| Drug | Meclofenamic Acid | 7.54e-07 | 14 | 122 | 4 | ctd:D008469 | |
| Drug | NSC86000 | 1.49e-06 | 5 | 122 | 3 | CID000257630 | |
| Drug | o-quinone | 2.61e-06 | 41 | 122 | 5 | CID000011421 | |
| Drug | oxcarbazepine | 2.86e-06 | 19 | 122 | 4 | ctd:C036006 | |
| Drug | AC1L93E5 | 2.97e-06 | 6 | 122 | 3 | CID000412383 | |
| Drug | Estazolam | 2.97e-06 | 6 | 122 | 3 | ctd:D004949 | |
| Drug | 3-hydroxyhexobarbital | 2.97e-06 | 6 | 122 | 3 | CID000439898 | |
| Drug | Glipizide | 2.97e-06 | 6 | 122 | 3 | ctd:D005913 | |
| Drug | acenaphthene-1-ol | 2.97e-06 | 6 | 122 | 3 | ctd:C023723 | |
| Drug | benzo(a)pyrene-7,8-dione | 3.56e-06 | 20 | 122 | 4 | ctd:C076588 | |
| Drug | Chrysenes | 3.56e-06 | 20 | 122 | 4 | ctd:D002911 | |
| Drug | Flunitrazepam | 4.38e-06 | 21 | 122 | 4 | ctd:D005445 | |
| Drug | 4-hydroxyequilenin-o-quinone | 5.17e-06 | 7 | 122 | 3 | ctd:C117714 | |
| Drug | zomepirac | 5.17e-06 | 7 | 122 | 3 | ctd:C020549 | |
| Drug | benzene dihydrodiol | 5.33e-06 | 22 | 122 | 4 | CID000000418 | |
| Drug | 2-cyclohexen-1-ol | 8.24e-06 | 8 | 122 | 3 | CID000013198 | |
| Drug | 9,10-phenanthrenequinone | 9.10e-06 | 25 | 122 | 4 | ctd:C005399 | |
| Drug | Pregnanolone | 9.10e-06 | 25 | 122 | 4 | ctd:D011280 | |
| Drug | benzo(a)pyrene 7,8-dihydrodiol | 2.21e-05 | 31 | 122 | 4 | ctd:C017228 | |
| Drug | 4-pyridinone | 2.40e-05 | 11 | 122 | 3 | CID000012290 | |
| Drug | NADP | 2.43e-05 | 107 | 122 | 6 | ctd:D009249 | |
| Drug | alpha-methylcinnamic acid | 2.85e-05 | 2 | 122 | 2 | ctd:C510582 | |
| Drug | (10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE | 2.85e-05 | 2 | 122 | 2 | DB07768 | |
| Drug | baccharin | 2.85e-05 | 2 | 122 | 2 | ctd:C012764 | |
| Drug | chlordecone | 3.01e-05 | 67 | 122 | 5 | CID000000299 | |
| Drug | fenamic acid | 3.19e-05 | 12 | 122 | 3 | ctd:C001209 | |
| Drug | 3,4-dichloroaniline | 3.87e-05 | 171 | 122 | 7 | ctd:C014464 | |
| Drug | 4-formyl-benzoate | 4.13e-05 | 13 | 122 | 3 | CID000012088 | |
| Drug | Piloty's acid | 4.13e-05 | 13 | 122 | 3 | CID000069033 | |
| Drug | Diazepam | 4.88e-05 | 74 | 122 | 5 | ctd:D003975 | |
| Drug | Dydrogesterone | 5.23e-05 | 14 | 122 | 3 | ctd:D004394 | |
| Drug | 6-.beta.-Naltrexol | 5.23e-05 | 14 | 122 | 3 | CID000631219 | |
| Drug | 20 alpha-dihydroprogesterone | 6.18e-05 | 40 | 122 | 4 | CID000008956 | |
| Drug | drospirenone | 6.52e-05 | 15 | 122 | 3 | ctd:C035144 | |
| Drug | cinnamyl alcohol | 7.50e-05 | 42 | 122 | 4 | ctd:C020722 | |
| Drug | 1,10-phenanthroline | 7.98e-05 | 82 | 122 | 5 | ctd:C025205 | |
| Drug | 9-cis-retinal | 7.99e-05 | 16 | 122 | 3 | ctd:C031390 | |
| Drug | Pyrimethamine [58-14-0]; Up 200; 16uM; PC3; HT_HG-U133A | 8.58e-05 | 194 | 122 | 7 | 4194_UP | |
| Drug | LY 294002; Up 200; 10uM; HL60; HT_HG-U133A | 8.58e-05 | 194 | 122 | 7 | 2687_UP | |
| Drug | 0198306-0000 [212631-61-3]; Down 200; 10uM; PC3; HT_HG-U133A | 9.44e-05 | 197 | 122 | 7 | 7069_DN | |
| Drug | benzo(a)pyrene-1,6-quinone | 9.66e-05 | 17 | 122 | 3 | ctd:C030233 | |
| Drug | Flufenamic Acid | 9.86e-05 | 45 | 122 | 4 | ctd:D005439 | |
| Drug | naphthalene-1,2-dihydrodiol | 9.86e-05 | 45 | 122 | 4 | CID000000362 | |
| Drug | cloxazolam | 1.15e-04 | 18 | 122 | 3 | CID000002816 | |
| Drug | Ruthenium Compounds | 1.15e-04 | 18 | 122 | 3 | ctd:D017975 | |
| Drug | benzo(a)pyrene-3,6-quinone | 1.15e-04 | 18 | 122 | 3 | ctd:C018003 | |
| Drug | AC1L8ZBW | 1.37e-04 | 19 | 122 | 3 | CID000435356 | |
| Drug | fenofibric acid | 1.61e-04 | 51 | 122 | 4 | ctd:C006012 | |
| Drug | androstane-3,17-dione | 1.61e-04 | 51 | 122 | 4 | CID000000443 | |
| Drug | AC1LAOJR | 1.70e-04 | 4 | 122 | 2 | CID000472179 | |
| Drug | MiADMSA | 1.70e-04 | 4 | 122 | 2 | CID000164448 | |
| Drug | coniferaldehyde | 1.86e-04 | 21 | 122 | 3 | ctd:C075384 | |
| Drug | Dutasteride | 1.86e-04 | 21 | 122 | 3 | ctd:D000068538 | |
| Drug | 1 C2 | 2.04e-04 | 100 | 122 | 5 | CID005327152 | |
| Drug | AC1O3IHE | 2.15e-04 | 22 | 122 | 3 | CID006329358 | |
| Drug | gramine | 2.15e-04 | 22 | 122 | 3 | CID000006890 | |
| Drug | Hexestrol | 2.17e-04 | 55 | 122 | 4 | ctd:D006589 | |
| Drug | chrysene | KLHL6 CAT SMOC2 TENM2 AKR1C1 YWHAZ DDX5 MED24 HMCN1 PTPRG PTPRZ1 YPEL5 GAB3 CD200 | 2.40e-04 | 871 | 122 | 14 | ctd:C031180 |
| Drug | 2'-Monophosphoadenosine 5'-Diphosphoribose | 2.46e-04 | 23 | 122 | 3 | DB03461 | |
| Drug | 1,2-dihydroxynaphthalene | 2.49e-04 | 57 | 122 | 4 | CID000011318 | |
| Drug | phenolphthalein | 2.66e-04 | 58 | 122 | 4 | CID000004764 | |
| Drug | NSC36919 | 2.66e-04 | 58 | 122 | 4 | CID000235496 | |
| Drug | Glyburide | 2.66e-04 | 58 | 122 | 4 | ctd:D005905 | |
| Drug | Flurbiprofen | 2.80e-04 | 107 | 122 | 5 | ctd:D005480 | |
| Drug | medazepam | 2.80e-04 | 24 | 122 | 3 | CID000004041 | |
| Drug | farnesal | 2.82e-04 | 5 | 122 | 2 | ctd:C084519 | |
| Disease | Neoplasms, Hormone-Dependent | 6.23e-08 | 3 | 118 | 3 | C0027661 | |
| Disease | Hermaphroditism | 6.20e-07 | 5 | 118 | 3 | C0019269 | |
| Disease | Ambiguous Genitalia | 6.20e-07 | 5 | 118 | 3 | C0266362 | |
| Disease | Pseudohermaphroditism | 6.20e-07 | 5 | 118 | 3 | C0033804 | |
| Disease | Intersex Conditions | 6.20e-07 | 5 | 118 | 3 | C2930618 | |
| Disease | Sex Differentiation Disorders | 6.20e-07 | 5 | 118 | 3 | C2930619 | |
| Disease | Cystic kidney | 1.24e-06 | 6 | 118 | 3 | C0022679 | |
| Disease | Disorders of Sex Development | 2.16e-06 | 7 | 118 | 3 | C0036875 | |
| Disease | Cystic Kidney Diseases | 1.00e-05 | 11 | 118 | 3 | C1691228 | |
| Disease | MALE PSEUDOHERMAPHRODITISM: DEFICIENCY OF TESTICULAR 17,20-DESMOLASE | 1.59e-05 | 2 | 118 | 2 | C1839840 | |
| Disease | 46,XY disorder of sex development due to testicular 17,20-desmolase deficiency | 1.59e-05 | 2 | 118 | 2 | cv:C1839840 | |
| Disease | 46,XY sex reversal 8 (is_implicated_in) | 1.59e-05 | 2 | 118 | 2 | DOID:0111773 (is_implicated_in) | |
| Disease | 46,XY SEX REVERSAL 8 | 1.59e-05 | 2 | 118 | 2 | 614279 | |
| Disease | nidogen-2 measurement | 9.46e-05 | 4 | 118 | 2 | EFO_0020608 | |
| Disease | methionine measurement | 1.52e-04 | 26 | 118 | 3 | EFO_0009771 | |
| Disease | Abnormalities, Drug-Induced | 1.57e-04 | 5 | 118 | 2 | C0000771 | |
| Disease | low density lipoprotein cholesterol measurement, body mass index | 2.35e-04 | 6 | 118 | 2 | EFO_0004340, EFO_0004611 | |
| Disease | cortolone glucuronide (1) measurement | 2.35e-04 | 6 | 118 | 2 | EFO_0800552 | |
| Disease | nephrolithiasis | 3.12e-04 | 33 | 118 | 3 | EFO_0004253 | |
| Disease | Endometrioma | 4.84e-04 | 161 | 118 | 5 | C0269102 | |
| Disease | Endometriosis | 4.84e-04 | 161 | 118 | 5 | C0014175 | |
| Disease | response to anticoagulant | 5.95e-04 | 41 | 118 | 3 | GO_0061476 | |
| Disease | ejection fraction measurement | 6.85e-04 | 43 | 118 | 3 | EFO_0005527 | |
| Disease | long QT syndrome (implicated_via_orthology) | 6.99e-04 | 10 | 118 | 2 | DOID:2843 (implicated_via_orthology) | |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 7.36e-04 | 101 | 118 | 4 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 | |
| Disease | cell growth regulator with EF hand domain protein 1 measurement | 8.52e-04 | 11 | 118 | 2 | EFO_0801461 | |
| Disease | urate measurement, bone density | 8.75e-04 | 619 | 118 | 9 | EFO_0003923, EFO_0004531 | |
| Disease | Drug habituation | 1.19e-03 | 115 | 118 | 4 | C0013170 | |
| Disease | Drug abuse | 1.19e-03 | 115 | 118 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 1.19e-03 | 115 | 118 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 1.19e-03 | 115 | 118 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 1.19e-03 | 115 | 118 | 4 | C0013222 | |
| Disease | Drug Dependence | 1.19e-03 | 115 | 118 | 4 | C1510472 | |
| Disease | Substance Dependence | 1.19e-03 | 115 | 118 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 1.19e-03 | 115 | 118 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.19e-03 | 115 | 118 | 4 | C0029231 | |
| Disease | Bardet-Biedl Syndrome | 1.20e-03 | 13 | 118 | 2 | C0752166 | |
| Disease | Substance abuse problem | 1.23e-03 | 116 | 118 | 4 | C0740858 | |
| Disease | Malignant neoplasm of breast | NID2 ABCA4 ANK2 RASGRF2 SYNE1 B3GALNT2 MECOM CAT SPAG6 SEMA3A PHKB PACC1 | 1.26e-03 | 1074 | 118 | 12 | C0006142 |
| Disease | Malignant neoplasm of stomach | 1.34e-03 | 300 | 118 | 6 | C0024623 | |
| Disease | 1-methylurate measurement | 1.40e-03 | 14 | 118 | 2 | EFO_0021173 | |
| Disease | BMI-adjusted leptin measurement | 1.61e-03 | 15 | 118 | 2 | EFO_0007793 | |
| Disease | 1,3,7-trimethylurate measurement | 1.61e-03 | 15 | 118 | 2 | EFO_0021172 | |
| Disease | Disorder of eye | 1.66e-03 | 212 | 118 | 5 | C0015397 | |
| Disease | insulin resistance | 1.72e-03 | 59 | 118 | 3 | EFO_0002614 | |
| Disease | testosterone measurement | ANK2 ERCC6L COBLL1 MECOM AKR1C4 AKR1C2 SEMA3A RGS14 ZNF800 PTPRF HMCN1 PTPRG AKR1C3 | 1.79e-03 | 1275 | 118 | 13 | EFO_0004908 |
| Disease | response to paliperidone, schizophrenia symptom severity measurement | 1.80e-03 | 216 | 118 | 5 | EFO_0007925, EFO_0007927 | |
| Disease | response to methotrexate | 1.83e-03 | 16 | 118 | 2 | GO_0031427 | |
| Disease | ovarian carcinoma | 1.88e-03 | 321 | 118 | 6 | EFO_0001075 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 2.07e-03 | 17 | 118 | 2 | EFO_0004611, EFO_0007800 | |
| Disease | Fetal Alcohol Syndrome | 2.07e-03 | 17 | 118 | 2 | C0015923 | |
| Disease | Colorectal Carcinoma | 2.08e-03 | 702 | 118 | 9 | C0009402 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 2.18e-03 | 447 | 118 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | Age-related macular degeneration | 2.33e-03 | 18 | 118 | 2 | cv:C0242383 | |
| Disease | serum hepcidin measurement | 2.33e-03 | 18 | 118 | 2 | EFO_0004504 | |
| Disease | Bardet-Biedl syndrome | 2.33e-03 | 18 | 118 | 2 | cv:C0752166 | |
| Disease | Neoplastic Cell Transformation | 2.39e-03 | 139 | 118 | 4 | C0007621 | |
| Disease | hip circumference | 2.43e-03 | 338 | 118 | 6 | EFO_0005093 | |
| Disease | Sclerocystic Ovaries | 2.71e-03 | 144 | 118 | 4 | C1136382 | |
| Disease | stroke | 2.71e-03 | 144 | 118 | 4 | EFO_0000712 | |
| Disease | Polycystic Ovary Syndrome | 2.71e-03 | 144 | 118 | 4 | C0032460 | |
| Disease | ulcerative colitis, Crohn's disease | 2.87e-03 | 20 | 118 | 2 | EFO_0000384, EFO_0000729 | |
| Disease | cortisol measurement | 2.87e-03 | 20 | 118 | 2 | EFO_0005843 | |
| Disease | gastric ulcer | 3.17e-03 | 21 | 118 | 2 | EFO_0009454 | |
| Disease | vitiligo (is_implicated_in) | 3.17e-03 | 21 | 118 | 2 | DOID:12306 (is_implicated_in) | |
| Disease | intellectual disability (implicated_via_orthology) | 3.41e-03 | 75 | 118 | 3 | DOID:1059 (implicated_via_orthology) | |
| Disease | prostate cancer (is_marker_for) | 3.62e-03 | 156 | 118 | 4 | DOID:10283 (is_marker_for) | |
| Disease | unipolar depression, bipolar disorder | 3.62e-03 | 156 | 118 | 4 | EFO_0003761, MONDO_0004985 | |
| Disease | smoking status measurement, diastolic blood pressure | 3.87e-03 | 159 | 118 | 4 | EFO_0006336, EFO_0006527 | |
| Disease | Liver Cirrhosis, Experimental | 3.96e-03 | 774 | 118 | 9 | C0023893 | |
| Disease | free androgen index | 4.00e-03 | 374 | 118 | 6 | EFO_0007005 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RTQRNYLVQTEEQYI | 1096 | P23470 | |
| SYNEQRIRENIQVFE | 271 | P17516 | |
| VGQRFLVNRVQDYIQ | 221 | O60825 | |
| NDDNVTQVRAFYVNV | 436 | P04040 | |
| TQVRAFYVNVLNEEQ | 441 | P04040 | |
| VDRLNITFYENQITA | 946 | P78363 | |
| SYNEQRIRQNVQVFE | 271 | P42330 | |
| RVENYLISTANEFVQ | 1881 | Q86UK0 | |
| RGYLQVNVTVQDIND | 231 | Q6V0I7 | |
| TTIRVYFNILDVNDN | 1926 | Q6V0I7 | |
| LDRESQSFYNLVVQV | 2006 | Q6V0I7 | |
| EIYNFVQQLAERFVS | 61 | P58335 | |
| SVAQAVQHLQVQERY | 146 | Q8TAB5 | |
| AVLAYSNVQEREAQF | 121 | Q96SW2 | |
| AQRLFENYQTQSEEV | 131 | Q9H2F9 | |
| DNETFRISVYQVLQE | 186 | P18075 | |
| RNFAQSNQYQVVDDI | 316 | Q9UBU7 | |
| NAETQFRQLVAIYEV | 101 | Q96KC8 | |
| QENVVQNEIIVYPEN | 516 | Q53SF7 | |
| EIVLENNYTAFQNAR | 131 | O60258 | |
| QQFEETVRTLNNLYA | 41 | Q7Z5G4 | |
| EYQFAVNNDTTELQV | 476 | Q8TDY8 | |
| INLDQEEVYRTQVVE | 66 | Q15283 | |
| ERVAGALQAQVEYNQ | 316 | H3BPF8 | |
| ERVAGELQAQVEYNQ | 111 | Q08AF8 | |
| EVFNQRLEQEYNASV | 411 | Q8N442 | |
| EETIYQNYQRIRIQE | 366 | P49736 | |
| NLVACQINDQIFYRV | 161 | Q03112 | |
| QINDQIFYRVVADIA | 166 | Q03112 | |
| IVQDQYVQEARQVFE | 586 | Q96PE2 | |
| TTQIQQYENVFIFET | 251 | Q7Z5J8 | |
| QIQESVTFASQVYRE | 1306 | Q01484 | |
| VVQNEQFDLIVNVFS | 691 | Q6IE37 | |
| VIITFRAQGEQEYQN | 1136 | O60840 | |
| FNQQLSTTIQEEFYR | 71 | Q14566 | |
| QEIFYTAIVNRTIAN | 476 | Q9NRZ9 | |
| YIIQNFVQILNSEEF | 196 | Q8WZ60 | |
| QEQRLQGEVVAFDYQ | 21 | Q3MHD2 | |
| FNQQVRARIYEVEQQ | 416 | Q86YW9 | |
| VQRYQEFINTLQFQV | 581 | Q8IV33 | |
| EAQLYRQFTTTVQVV | 36 | Q14439 | |
| ENFQQVIDRTVSLYE | 76 | Q6ZRS4 | |
| ARNELQTVYEAFVQQ | 981 | Q9ULD2 | |
| QNAAVFQEAFEIVVR | 106 | P51654 | |
| ILINFRTTYVNQNEE | 466 | Q9NS40 | |
| QRVDYVQVDEQKTQA | 556 | Q8WWW8 | |
| AAIQDFQVRQYIEQL | 1036 | Q2LD37 | |
| VINFRTTYVNTNDEV | 316 | Q9H252 | |
| TRELAQQVQQVAAEY | 176 | P17844 | |
| QVRVAELINASYFNN | 296 | P0C7V8 | |
| TNQDVINAIEQDYRL | 831 | P29323 | |
| QVLSQEQYERVLAEN | 1406 | Q9C000 | |
| QQLSVDSVFVLYNQE | 631 | P14543 | |
| QQTRQQQYEEQIPFY | 166 | A1E959 | |
| DQFDQAVVLNQLRYS | 646 | Q9HD67 | |
| REYEAREQTDQTQVQ | 41 | P0C7V9 | |
| VFNQFRVVLSQQEQE | 421 | Q9HAQ2 | |
| QRNYLVQTEEQYVFI | 1971 | P23471 | |
| ENADYVEQAIIQTVR | 706 | Q6IE36 | |
| QIQIIYFNLETVQVT | 31 | Q9HC73 | |
| VQTREPYEVAQFNVE | 156 | Q86XP1 | |
| QSIENYVQIDITRVF | 751 | Q9Y2A7 | |
| YNTTFQERVANQRIE | 1271 | Q96RW7 | |
| ELLANQYSIQVQVED | 326 | Q96CB9 | |
| AQRVNLVQTEEQYVF | 1121 | O14522 | |
| QVQVVTQDEREQLYT | 31 | P41217 | |
| VEFRQETSVVNYIDQ | 256 | Q9H813 | |
| IVQNLEAENYNIESA | 251 | Q5T2D3 | |
| TQQLNVDRVFALYND | 721 | Q14112 | |
| TRYFVIIQANDRAQN | 226 | Q96QU1 | |
| ATVDSVYAREQINQQ | 876 | A1KZ92 | |
| VYAREQINQQTAYID | 881 | A1KZ92 | |
| QRYNDIIQQDFVDSF | 151 | Q9BYG0 | |
| VQNAEDVYEAVRTQS | 421 | O43464 | |
| ERVAGALQAQVEYNQ | 111 | Q0D2H9 | |
| EQRVVIFEQTQYDVP | 181 | Q6ISB3 | |
| VSEQIVSFYRVNEVQ | 1421 | Q14185 | |
| ETERQIYQQDSAIEN | 71 | Q5T0U0 | |
| FQSQDYVELTFEQQV | 121 | Q9UKA2 | |
| FQRNITVKLYQAEQE | 171 | Q8NCR0 | |
| QLNRYFTQQEISDAI | 681 | A8TX70 | |
| YSEVFEAINITNNER | 51 | P19784 | |
| NVNAEISVFEVNIRF | 271 | P33908 | |
| IISQQYNFDRDNTEV | 911 | P14735 | |
| SDIEQEAQINYDRQV | 631 | Q6ZMW3 | |
| RQVVQYEIDFQDVTT | 101 | Q17R55 | |
| TNNTQLRVDYVIFDN | 206 | Q17R55 | |
| IQQTFQQYASLREEE | 231 | Q14289 | |
| QNNYRVTVIFRDVQL | 2041 | Q9UGM3 | |
| EAYNETFSNRVIINE | 96 | Q92503 | |
| SVDVSQDYNQVENVI | 91 | Q06136 | |
| RVFQDRQYQIDAAIV | 841 | Q13620 | |
| YIQQRVQKAQFLVEF | 696 | Q2NKX8 | |
| QIIYNTDEVSFIQNL | 191 | Q93100 | |
| FRILVQQFEVQLQQY | 346 | Q9BVL2 | |
| YTVVFRDINSQQELQ | 951 | P10586 | |
| LQQEIFRYIRNTVGQ | 966 | Q5HYA8 | |
| VRNQIIFAVRQEYVE | 51 | O96033 | |
| IQQNVADILFVRTSY | 2271 | Q93008 | |
| VQNTVQNLREYLEVE | 946 | Q9BQF6 | |
| VLQVFEQYQKARTQF | 6 | O75602 | |
| VEQLLQNYVSFIENS | 536 | Q8NF91 | |
| VDLNQVLNETRSQYE | 261 | O76011 | |
| QELYQVAQEQVRQGE | 496 | Q58EX7 | |
| EIRQFQQTSYRIDHQ | 1191 | O14827 | |
| QREASAYEQVKQVLQ | 331 | Q86SQ7 | |
| FSENTLQFYNERVVI | 651 | O75448 | |
| QTLVQNEAVFVQYLD | 531 | Q9NT68 | |
| ANQQETEQFYFTVRE | 441 | P0DJJ0 | |
| NQQETEQFYFTVREC | 441 | P0DMP2 | |
| ALERFYEQVVQAIQR | 181 | Q9BRX2 | |
| QVEVFRQNLFQEAEE | 16 | Q9UL46 | |
| DVNYQFTQIVVDRVD | 426 | Q14563 | |
| IVDQSQQAYQEAFEI | 141 | P63104 | |
| SYNEQRIRQNVQVFE | 271 | Q04828 | |
| SYNEQRIRQNVQVFE | 271 | P52895 | |
| RVSAFIENNIVVFEN | 31 | P56748 | |
| ANAIIRDFYNSIVNV | 141 | P56748 | |
| NKVVNLQYSEVQDRV | 46 | P62699 | |
| QEEVSRIINYNVEQE | 771 | Q12768 | |
| YENVENLEFVQNQEV | 456 | O15027 | |
| YTQEQARKEFQQVFI | 96 | Q9H3U7 | |
| YEEDVRIQNAINIAQ | 471 | C9JQI7 | |
| DAERVVNQYQELVQN | 401 | Q8NEM7 | |
| VQVAARQQEELLYQV | 76 | A0A0J9YWL9 | |
| TQQLAQEARNIYQEF | 111 | O43566 | |
| LQDQRQYIVAEFEQG | 181 | Q12899 | |
| QNEVDYRQKQVVILS | 46 | Q9BZX2 | |
| VDNLFVVVQEFQDYQ | 91 | Q9BV44 | |
| YQIQESVVVDQISQL | 861 | Q8IYT8 | |
| NTLERNFERINTVQY | 56 | Q96AP4 | |
| LEDQQQRAISNFYII | 66 | Q9BY10 | |
| IETNQNAVFQYISRT | 136 | Q2TB10 | |
| LQISENENYVVNAII | 116 | Q96NJ3 |